The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients

A. Feit, M. Cohen, L. Dimino, N. El-Sherif, R. Holtzman, C. V S Ram, D. Gaffeny, J. A. Heller, Norman M Kaplan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP ≤ 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently re-exercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P < 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.

Original languageEnglish (US)
Pages (from-to)39-43
Number of pages5
JournalJournal of Human Hypertension
Volume5
Issue number1
StatePublished - 1991

Fingerprint

Labetalol
Prazosin
Hemodynamics
Exercise
Antihypertensive Agents
Heart Rate
Myocardial Ischemia
Fatigue
Placebos
Pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Feit, A., Cohen, M., Dimino, L., El-Sherif, N., Holtzman, R., Ram, C. V. S., ... Kaplan, N. M. (1991). The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients. Journal of Human Hypertension, 5(1), 39-43.

The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients. / Feit, A.; Cohen, M.; Dimino, L.; El-Sherif, N.; Holtzman, R.; Ram, C. V S; Gaffeny, D.; Heller, J. A.; Kaplan, Norman M.

In: Journal of Human Hypertension, Vol. 5, No. 1, 1991, p. 39-43.

Research output: Contribution to journalArticle

Feit, A, Cohen, M, Dimino, L, El-Sherif, N, Holtzman, R, Ram, CVS, Gaffeny, D, Heller, JA & Kaplan, NM 1991, 'The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients', Journal of Human Hypertension, vol. 5, no. 1, pp. 39-43.
Feit A, Cohen M, Dimino L, El-Sherif N, Holtzman R, Ram CVS et al. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients. Journal of Human Hypertension. 1991;5(1):39-43.
Feit, A. ; Cohen, M. ; Dimino, L. ; El-Sherif, N. ; Holtzman, R. ; Ram, C. V S ; Gaffeny, D. ; Heller, J. A. ; Kaplan, Norman M. / The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients. In: Journal of Human Hypertension. 1991 ; Vol. 5, No. 1. pp. 39-43.
@article{a255590027964e3596a515070d95b746,
title = "The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients",
abstract = "The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP ≤ 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently re-exercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P < 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.",
author = "A. Feit and M. Cohen and L. Dimino and N. El-Sherif and R. Holtzman and Ram, {C. V S} and D. Gaffeny and Heller, {J. A.} and Kaplan, {Norman M}",
year = "1991",
language = "English (US)",
volume = "5",
pages = "39--43",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients

AU - Feit, A.

AU - Cohen, M.

AU - Dimino, L.

AU - El-Sherif, N.

AU - Holtzman, R.

AU - Ram, C. V S

AU - Gaffeny, D.

AU - Heller, J. A.

AU - Kaplan, Norman M

PY - 1991

Y1 - 1991

N2 - The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP ≤ 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently re-exercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P < 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.

AB - The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP ≤ 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently re-exercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P < 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.

UR - http://www.scopus.com/inward/record.url?scp=0026078579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026078579&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 39

EP - 43

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 1

ER -